American Society for Gastrointestinal Endoscopy   Report issue

Foundation Phase 1 Phase 2 Phase 3 Phase 4
Founded: Downers Grove IL United States (1941)

Organization Overview

First Clinical Trial
2004
NCT00123656
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

ASGE

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 1)

Carcinoma, Acinar Cell (Phase 1)

Eosinophilic Esophagitis (Phase 2)

Esophagitis (Phase 2)

Pancreatic Neoplasms (Phase 1)

Pancreatitis (Phase 3)

Pancreatitis, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 12